Envoy Medical COCH
NASDAQ COCH
$0.75 +0.01 (+1.41%)
At close: Aug 20, 2026 · 4:00 PM EDT

Envoy Medical (COCH) Notes Payables (2022 - 2023)

Envoy Medical (COCH) posted Notes Payables of $311000.0 for Q4 2023, up 36.4% sequentially from $228000.0 in Q3 2023, and down 7.16% YoY from $335000.0 in Q4 2022.

Envoy Medical (COCH) Notes Payables (2022 - 2023) Analysis & Trends

Envoy Medical has reported Notes Payables for 2 years, with the latest figure at $311000.0 in Q4 2023.

  • Quarterly Notes Payables fell 7.16% year-over-year to $311000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $311000.0 (down 7.16% YoY) and the FY2023 annual result came in at $311000.0, down 7.16% from the prior year.
  • Notes Payables improved to $311000.0 in Q4 2023 per COCH's latest filing, from $228000.0 in the prior quarter.
  • Over five years, Notes Payables peaked at $335000.0 in Q4 2022 and troughed at $228000.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Envoy Medical 77.82 Mn 58.14 Mn -227,000.00

Historic Data

Download Data
DateValue
Dec 31, 2023 311,000.00
Sep 30, 2023 228,000.00
Dec 31, 2022 335,000.00